<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35868478</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-1186</ISSN><JournalIssue CitedMedium="Internet"><Volume>183</Volume><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Pharmacological research</Title><ISOAbbreviation>Pharmacol Res</ISOAbbreviation></Journal><ArticleTitle>Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey.</ArticleTitle><Pagination><StartPage>106360</StartPage><MedlinePgn>106360</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.phrs.2022.106360</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1043-6618(22)00305-X</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Recent evidence suggests that oxidative stress and endothelial dysfunction play critical roles in the pathophysiology of COVID-19 and Long-COVID. We hypothesized that a supplementation combining L-Arginine (to improve endothelial function) and Vitamin C (to reduce oxidation) could have favorable effects on Long-COVID symptoms.</AbstractText><AbstractText Label="METHODS">We designed a survey (LINCOLN: L-Arginine and Vitamin C improves Long-COVID), assessing several symptoms that have been associated with Long-COVID to be administered nationwide to COVID-19 survivors; the survey also included effort perception, measured using the Borg scale. Patients receiving the survey were divided in two groups, with a 2:1 ratio: the first group included patients that received L-Arginine + Vitamin C, whereas the second group received a multivitamin combination (alternative treatment).</AbstractText><AbstractText Label="RESULTS">1390 patients successfully completed the survey. Following a 30-day treatment in both groups, the survey revealed that patients in the L-Arginine + Vitamin C treatment arm had significantly lower scores compared to patients who had received the multivitamin combination. There were no other significant differences between the two groups. When examining effort perception, we observed a significantly lower value (p&#xa0;&lt;&#xa0;0.0001) in patients receiving L-Arginine + Vitamin C compared to the alternative-treatment arm.</AbstractText><AbstractText Label="CONCLUSIONS">Our survey indicates&#xa0;that the supplementation with L-Arginine + Vitamin C has beneficial effects in Long-COVID, in terms of attenuating its typical symptoms and improving effort perception.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Izzo</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trimarco</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Reproductive Sciences and Dentistry, Federico II University, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mone</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Albert Einstein College of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alo&#xe8;</LastName><ForeName>Teresita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>San Martino Hospital, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capra Marzani</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Alessandria Hospital, Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diana</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Aversa Hospital, Aversa, Caserta, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fazio</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Palermo Hospital, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallardo</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>"San Gennaro" Hospital, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maniscalco</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Istituti Clinici Scientifici Maugeri IRCCS, Telese Terme, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marazzi</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>San Raffaele Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Nunzia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>ASL Napoli 1, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mininni</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Associazione Scientifica Interdisciplinare Aggiornamento Medico (ASIAM), Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mussi</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Metabolic Sciences and Neuroscience, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelaia</LastName><ForeName>Girolamo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Science, Magna Graecia University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pennisi</LastName><ForeName>Alfio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Catania Hospital, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santus</LastName><ForeName>Pierachille</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>"Luigi Sacco" University Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scarpelli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Trani Hospital, Trani, BT, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tursi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Codogno Hospital, ASST Lodi, Lodi, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanforlin</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Authority of South Tyrol, Bolzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santulli</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy; Department of Medicine, Albert Einstein College of Medicine, New York, NY, USA. Electronic address: gsantulli001@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trimarco</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Pharmacol Res</MedlineTA><NlmUniqueID>8907422</NlmUniqueID><ISSNLinking>1043-6618</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014815">Vitamins</NameOfSubstance></Chemical><Chemical><RegistryNumber>94ZLA3W45F</RegistryNumber><NameOfSubstance UI="D001120">Arginine</NameOfSubstance></Chemical><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001205" MajorTopicYN="Y">Ascorbic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014815" MajorTopicYN="N">Vitamins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ascorbic acid</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Endothelial dysfunction</Keyword><Keyword MajorTopicYN="N">L-Arginine</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword><Keyword MajorTopicYN="N">Survey</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>22</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35868478</ArticleId><ArticleId IdType="pmc">PMC9295384</ArticleId><ArticleId IdType="doi">10.1016/j.phrs.2022.106360</ArticleId><ArticleId IdType="pii">S1043-6618(22)00305-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Page J.H., et al. Trends in characteristics and outcomes among US adults hospitalised with COVID-19 throughout 2020: an observational cohort study. BMJ Open. 2022;12 doi: 10.1136/bmjopen-2021-055137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-055137</ArticleId><ArticleId IdType="pmc">PMC8886119</ArticleId><ArticleId IdType="pubmed">35228287</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolahchi Z., De Domenico M., Uddin LQ., Cauda V., Grossmann I., Lacasa L., Grancini G., Mahmoudi M., Rezaei R. COVID-19 and Its Global Economic Impact. Adv. Exp. Med. Biol. 2021;1318:825&#x2013;837. doi: 10.1007/978-3-030-63761-3_46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-63761-3_46</ArticleId><ArticleId IdType="pubmed">33973214</ArticleId></ArticleIdList></Reference><Reference><Citation>Boggiano C., et al. Update on and future directions for use of anti-SARS-CoV-2 antibodies: National Institutes of Health Summit on Treatment and Prevention of COVID-19. Ann. Intern. Med. 2022;175:119&#x2013;126. doi: 10.7326/M21-3669.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-3669</ArticleId><ArticleId IdType="pmc">PMC8559823</ArticleId><ArticleId IdType="pubmed">34724404</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens D.M., Taubenberger J.K., Fauci A.S. Universal coronavirus vaccines - an urgent need. N. Engl. J. Med. 2022;386:297&#x2013;299. doi: 10.1056/NEJMp2118468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2118468</ArticleId><ArticleId IdType="pmc">PMC11000439</ArticleId><ArticleId IdType="pubmed">34910863</ArticleId></ArticleIdList></Reference><Reference><Citation>Sievers B.L., et al. Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses. Sci. Transl. Med. eabn7842. 2022 doi: 10.1126/scitranslmed.abn7842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abn7842</ArticleId><ArticleId IdType="pmc">PMC8891085</ArticleId><ArticleId IdType="pubmed">35025672</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauci A.S. The story behind COVID-19 vaccines. Science. 2021;372:109. doi: 10.1126/science.abi8397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abi8397</ArticleId><ArticleId IdType="pubmed">33833099</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai A.D., Lavelle M., Boursiquot B.C., Wan E.Y. Long-term complications of COVID-19. Am. J. Physiol. Cell Physiol. 2022;322:C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rio C., Collins L.F., Malani P. Long-term health consequences of COVID-19. JAMA. 2020 doi: 10.1001/jama.2020.19719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19719</ArticleId><ArticleId IdType="pmc">PMC8019677</ArticleId><ArticleId IdType="pubmed">33031513</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaffney A.W. The long COVID conundrum. Am. J. Med. 2022;135:5&#x2013;6. doi: 10.1016/j.amjmed.2021.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2021.07.037</ArticleId><ArticleId IdType="pmc">PMC8379817</ArticleId><ArticleId IdType="pubmed">34428463</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Misra A. Post COVID-19 syndrome (&#x201c;Long COVID&#x201d;) and diabetes: challenges in diagnosis and management. Diabetes Metab. Syndr. 2021;15 doi: 10.1016/j.dsx.2021.102235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.102235</ArticleId><ArticleId IdType="pmc">PMC8317446</ArticleId><ArticleId IdType="pubmed">34384972</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Pittet L.F., Curtis N. Long COVID in children and adolescents. BMJ. 2022;376:o143. doi: 10.1136/bmj.o143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o143</ArticleId><ArticleId IdType="pubmed">35058281</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegelman J.N. Reflections of a COVID-19 Long Hauler. JAMA. 2020;324:2031&#x2013;2032. doi: 10.1001/jama.2020.22130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22130</ArticleId><ArticleId IdType="pubmed">33175108</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman E.L., et al. COVID-19 and diabetes: a collision and collusion of two diseases. Diabetes. 2020;69:2549&#x2013;2565. doi: 10.2337/dbi20-0032.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dbi20-0032</ArticleId><ArticleId IdType="pmc">PMC7679769</ArticleId><ArticleId IdType="pubmed">32938731</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: an overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokes A.C., et al. COVID-19 and excess mortality in the United States: a county-level analysis. PLoS Med. 2021;18 doi: 10.1371/journal.pmed.1003571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003571</ArticleId><ArticleId IdType="pmc">PMC8136644</ArticleId><ArticleId IdType="pubmed">34014945</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T., Anton M.C., Sivakumar T. New-onset diabetes in &#x201c;long COVID&#x201d;. J. Diabetes. 2021;13:693&#x2013;694. doi: 10.1111/1753-0407.13187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1753-0407.13187</ArticleId><ArticleId IdType="pmc">PMC8251301</ArticleId><ArticleId IdType="pubmed">33893710</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L., et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat. Metab. 2021 doi: 10.1038/s42255-021-00407-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauci A.S., Lane H.C., Redfield R.R. Covid-19 - navigating the uncharted. N. Engl. J. Med. 2020;382:1268&#x2013;1269. doi: 10.1056/NEJMe2002387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2002387</ArticleId><ArticleId IdType="pmc">PMC7121221</ArticleId><ArticleId IdType="pubmed">32109011</ArticleId></ArticleIdList></Reference><Reference><Citation>Paules C.I., Fauci A.S. COVID-19: the therapeutic landscape. Med. (N. Y.) 2021;2:493&#x2013;497. doi: 10.1016/j.medj.2021.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.04.015</ArticleId><ArticleId IdType="pmc">PMC8057546</ArticleId><ArticleId IdType="pubmed">33899041</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoehl S., et al. Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China. N. Engl. J. Med. 2020;382:1278&#x2013;1280. doi: 10.1056/NEJMc2001899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2001899</ArticleId><ArticleId IdType="pmc">PMC7121749</ArticleId><ArticleId IdType="pubmed">32069388</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou L., et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 2020;382:1177&#x2013;1179. doi: 10.1056/NEJMc2001737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2001737</ArticleId><ArticleId IdType="pmc">PMC7121626</ArticleId><ArticleId IdType="pubmed">32074444</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheahan T.P., Frieman M.B. The continued epidemic threat of SARS-CoV-2 and implications for the future of global public health. Curr. Opin. Virol. 2020;40:37&#x2013;40. doi: 10.1016/j.coviro.2020.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2020.05.010</ArticleId><ArticleId IdType="pmc">PMC7269927</ArticleId><ArticleId IdType="pubmed">32569751</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19:141&#x2013;154. doi: 10.1038/s41579-020-00459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Accili D. Can COVID-19 cause diabetes? Nat. Metab. 2021;3:123&#x2013;125. doi: 10.1038/s42255-020-00339-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-020-00339-7</ArticleId><ArticleId IdType="pmc">PMC8892570</ArticleId><ArticleId IdType="pubmed">33432203</ArticleId></ArticleIdList></Reference><Reference><Citation>Denson J.L., et al. Metabolic syndrome and acute respiratory distress syndrome in hospitalized patients With COVID-19. JAMA Netw. Open. 2021;4 doi: 10.1001/jamanetworkopen.2021.40568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.40568</ArticleId><ArticleId IdType="pmc">PMC8696573</ArticleId><ArticleId IdType="pubmed">34935924</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C., et al. Hypertension, thrombosis, kidney failure, and diabetes: Is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J. Clin. Med. 2020;9:1417. doi: 10.3390/jcm9051417.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9051417</ArticleId><ArticleId IdType="pmc">PMC7290769</ArticleId><ArticleId IdType="pubmed">32403217</ArticleId></ArticleIdList></Reference><Reference><Citation>Santulli G., Morelli M., Gambardella J. Is endothelial dysfunction the concealed cornerstone of COVID-19? BMJ. 2020;368</Citation></Reference><Reference><Citation>Qin Z., et al. Endothelial cell infection and dysfunction, immune activation in severe COVID-19. Theranostics. 2021;11:8076&#x2013;8091. doi: 10.7150/thno.61810.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.61810</ArticleId><ArticleId IdType="pmc">PMC8315069</ArticleId><ArticleId IdType="pubmed">34335981</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P., Luscher T. COVID-19 is, in the end, an endothelial disease. Eur. Heart J. 2020;41:3038&#x2013;3044. doi: 10.1093/eurheartj/ehaa623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S.X., et al. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat. Rev. Cardiol. 2020 doi: 10.1038/s41569-020-00469-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00469-1</ArticleId><ArticleId IdType="pmc">PMC7675396</ArticleId><ArticleId IdType="pubmed">33214651</ArticleId></ArticleIdList></Reference><Reference><Citation>Perea Polak A., et al. Complement-mediated thrombogenic vasculopathy in COVID-19. Int J. Dermatol. 2020 doi: 10.1111/ijd.15267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijd.15267</ArticleId><ArticleId IdType="pmc">PMC7753700</ArticleId><ArticleId IdType="pubmed">33259066</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuwen L.A., Geldhof V., Pasut A., Carmeliet P. COVID-19: the vasculature unleashed. Nat. Rev. Immunol. 2020;20:389&#x2013;391. doi: 10.1038/s41577-020-0343-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0343-0</ArticleId><ArticleId IdType="pmc">PMC7240244</ArticleId><ArticleId IdType="pubmed">32439870</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesquida J., et al. Peripheral microcirculatory alterations are associated with the severity of acute respiratory distress syndrome in COVID-19 patients admitted to intermediate respiratory and intensive care units. Crit. Care. 2021;25:381. doi: 10.1186/s13054-021-03803-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03803-2</ArticleId><ArticleId IdType="pmc">PMC8575160</ArticleId><ArticleId IdType="pubmed">34749792</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmaier A.A., et al. Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19. JCI Insight. 2021;6 doi: 10.1172/jci.insight.151527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.151527</ArticleId><ArticleId IdType="pmc">PMC8564889</ArticleId><ArticleId IdType="pubmed">34506304</ArticleId></ArticleIdList></Reference><Reference><Citation>Otifi H.M., Adiga B.K. Endothelial dysfunction in Covid-19. Am. J. Med. Sci. 2022 doi: 10.1016/j.amjms.2021.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2021.12.010</ArticleId><ArticleId IdType="pmc">PMC8802031</ArticleId><ArticleId IdType="pubmed">35093394</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelliher S., et al. Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis. J. Thromb. Haemost. 2022 doi: 10.1111/jth.15660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15660</ArticleId><ArticleId IdType="pmc">PMC9305123</ArticleId><ArticleId IdType="pubmed">35102689</ArticleId></ArticleIdList></Reference><Reference><Citation>Amraei R., et al. Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 2022;119 doi: 10.1073/pnas.2113874119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2113874119</ArticleId><ArticleId IdType="pmc">PMC8833221</ArticleId><ArticleId IdType="pubmed">35078919</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella, J. &amp; Santulli, G. What is linking COVID-19 and endothelial dysfunction? Updates on nanomedicine and bioengineering from the 2020 AHA Scientific Sessions. European Heart Journal (Cardiovascular Pharmacotherapy), In press 7 (2021) e2-e3, 10.1093/ehjcvp/pvaa145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcvp/pvaa145</ArticleId><ArticleId IdType="pmc">PMC7799225</ArticleId><ArticleId IdType="pubmed">33377481</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur S., Tripathi D.M., Yadav A. The enigma of endothelium in COVID-19. Front Physiol. 2020;11:989. doi: 10.3389/fphys.2020.00989.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00989</ArticleId><ArticleId IdType="pmc">PMC7417426</ArticleId><ArticleId IdType="pubmed">32848893</ArticleId></ArticleIdList></Reference><Reference><Citation>Matarese A., Gambardella J., Sardu C., Santulli G. miR-98 Regulates TMPRSS2 expression in human endothelial cells: key implications for COVID-19. Biomedicines. 2020;8:462. doi: 10.3390/biomedicines8110462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8110462</ArticleId><ArticleId IdType="pmc">PMC7693865</ArticleId><ArticleId IdType="pubmed">33143053</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmetaj-Shala B., et al. Cardiorenal tissues express SARS-CoV-2 entry genes and basigin (BSG/CD147) increases with age in endothelial cells. JACC Basic Transl. Sci. 2020;5:1111&#x2013;1123. doi: 10.1016/j.jacbts.2020.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2020.09.010</ArticleId><ArticleId IdType="pmc">PMC7546186</ArticleId><ArticleId IdType="pubmed">33073064</ArticleId></ArticleIdList></Reference><Reference><Citation>Mone P., et al. miR-24 targets the transmembrane glycoprotein neuropilin-1 in human brain microvascular endothelial cells. Noncoding RNA. 2021;7:9. doi: 10.3390/ncrna7010009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ncrna7010009</ArticleId><ArticleId IdType="pmc">PMC7931075</ArticleId><ArticleId IdType="pubmed">33540664</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts K.A., Colley L., Agbaedeng T.A., Ellison-Hughes G.M., Ross M.D. Vascular manifestations of COVID-19 - thromboembolism and microvascular dysfunction. Front Cardiovasc Med. 2020;7 doi: 10.3389/fcvm.2020.598400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.598400</ArticleId><ArticleId IdType="pmc">PMC7649150</ArticleId><ArticleId IdType="pubmed">33195487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz M.E., et al. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract. EBioMedicine. 2020;60 doi: 10.1016/j.ebiom.2020.102976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102976</ArticleId><ArticleId IdType="pmc">PMC7505653</ArticleId><ArticleId IdType="pubmed">32971472</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelesidis T., et al. The ApoA-I mimetic peptide 4F attenuates in vitro replication of SARS-CoV-2, associated apoptosis, oxidative stress and inflammation in epithelial cells. Virulence. 2021;12:2214&#x2013;2227. doi: 10.1080/21505594.2021.1964329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2021.1964329</ArticleId><ArticleId IdType="pmc">PMC8437485</ArticleId><ArticleId IdType="pubmed">34494942</ArticleId></ArticleIdList></Reference><Reference><Citation>Varzideh F., et al. Sortilin drives hypertension by modulating sphingolipid/ceramide homeostasis and by triggering oxidative stress. J. Clin. Invest. 2022;132 doi: 10.1172/JCI156624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI156624</ArticleId><ArticleId IdType="pmc">PMC8803317</ArticleId><ArticleId IdType="pubmed">35104807</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella J., et al. Role of endothelial G protein-coupled receptor kinase 2 in angioedema. Hypertension. 2020;76:1625&#x2013;1636. doi: 10.1161/HYPERTENSIONAHA.120.15130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15130</ArticleId><ArticleId IdType="pmc">PMC7544666</ArticleId><ArticleId IdType="pubmed">32895019</ArticleId></ArticleIdList></Reference><Reference><Citation>Mone P., et al. SGLT2 inhibition via empagliflozin Improves endothelial function and reduces mitochondrial oxidative stress: Insights from frail hypertensive and diabetic patients. Hypertension. 2022;79:1633&#x2013;1643. doi: 10.1161/HYPERTENSIONAHA.122.19586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.122.19586</ArticleId><ArticleId IdType="pmc">PMC9642044</ArticleId><ArticleId IdType="pubmed">35703100</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., et al. Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan, China: prevalence, risk factors, and outcome. Circulation. 2020;142:114&#x2013;128. doi: 10.1161/CIRCULATIONAHA.120.046702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.046702</ArticleId><ArticleId IdType="pubmed">32421381</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagashima S., et al. Endothelial dysfunction and thrombosis in patients with COVID-19-brief report. Arterioscler. Thromb. Vasc. Biol. 2020;40:2404&#x2013;2407. doi: 10.1161/ATVBAHA.120.314860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.314860</ArticleId><ArticleId IdType="pmc">PMC7505138</ArticleId><ArticleId IdType="pubmed">32762443</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhard-Koren N.M., et al. Higher prevalence of pulmonary macrothrombi in SARS-CoV-2 than in influenza A: autopsy results from &#x2018;Spanish flu&#x2019; 1918/1919 in Switzerland to Coronavirus disease 2019. J. Pathol. Clin. Res. 2020 doi: 10.1002/cjp2.189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cjp2.189</ArticleId><ArticleId IdType="pmc">PMC7869934</ArticleId><ArticleId IdType="pubmed">33185036</ArticleId></ArticleIdList></Reference><Reference><Citation>Izcovich A., et al. Prognostic factors for severity and mortality in patients infected with COVID-19: a systematic review. PLoS One. 2020;15 doi: 10.1371/journal.pone.0241955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241955</ArticleId><ArticleId IdType="pmc">PMC7671522</ArticleId><ArticleId IdType="pubmed">33201896</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino G., et al. Effects of adding L-arginine orally to standard therapy in patients with COVID-19: a randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis. EClinicalMedicine. 2021;40 doi: 10.1016/j.eclinm.2021.101125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101125</ArticleId><ArticleId IdType="pmc">PMC8428476</ArticleId><ArticleId IdType="pubmed">34522871</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson P.I., et al. The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng/kg/min for 72&#x2009;h compared to placebo in mechanically ventilated patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial. Trials. 2020;21:746. doi: 10.1186/s13063-020-04696-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-020-04696-2</ArticleId><ArticleId IdType="pmc">PMC7447606</ArticleId><ArticleId IdType="pubmed">32847626</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Zhu Y., Zhang J., Li Y., Peng Z. Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial. BMJ Open. 2020;10 doi: 10.1136/bmjopen-2020-039519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-039519</ArticleId><ArticleId IdType="pmc">PMC7348463</ArticleId><ArticleId IdType="pubmed">32641343</ArticleId></ArticleIdList></Reference><Reference><Citation>Adebayo A., et al. l-Arginine and COVID-19: an update. Nutrients. 2021;13 doi: 10.3390/nu13113951.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13113951</ArticleId><ArticleId IdType="pmc">PMC8619186</ArticleId><ArticleId IdType="pubmed">34836206</ArticleId></ArticleIdList></Reference><Reference><Citation>Leucker T.M., et al. Effect of crizanlizumab, a P-selectin inhibitor, in COVID-19: a placebo-controlled, randomized trial. JACC Basic Transl. Sci. 2021;6:935&#x2013;945. doi: 10.1016/j.jacbts.2021.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.09.013</ArticleId><ArticleId IdType="pmc">PMC8653991</ArticleId><ArticleId IdType="pubmed">34904132</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z., Yang K.Y., Huang Y., Lui K.O. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications. J. Mol. Cell Cardiol. 2021;164:69&#x2013;82. doi: 10.1016/j.yjmcc.2021.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2021.11.010</ArticleId><ArticleId IdType="pmc">PMC8610843</ArticleId><ArticleId IdType="pubmed">34838588</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., et al. A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: a structured summary of a study protocol for a randomized controlled trial. Trials. 2021;22:451. doi: 10.1186/s13063-021-05361-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05361-y</ArticleId><ArticleId IdType="pmc">PMC8280682</ArticleId><ArticleId IdType="pubmed">34266452</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava S., Garg I., Hembrom A.A., Kumar B. Assessment of nitric oxide (NO) potential to mitigate COVID-19 severity. Virusdisease. 2021;32:589&#x2013;594. doi: 10.1007/s13337-021-00702-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13337-021-00702-6</ArticleId><ArticleId IdType="pmc">PMC8173103</ArticleId><ArticleId IdType="pubmed">34099981</ArticleId></ArticleIdList></Reference><Reference><Citation>Isidori A.M., et al. Targeting the NO-cGMP-PDE5 pathway in COVID-19 infection. The DEDALO project. Andrology. 2021;9:33&#x2013;38. doi: 10.1111/andr.12837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.12837</ArticleId><ArticleId IdType="pmc">PMC7307129</ArticleId><ArticleId IdType="pubmed">32526061</ArticleId></ArticleIdList></Reference><Reference><Citation>Brosnan M.E., Brosnan J.T. Renal arginine metabolism. J. Nutr. 2004;134(2791S&#x2013;2795S):2796S&#x2013;2797S. doi: 10.1093/jn/134.10.2791S. (discussion)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/134.10.2791S</ArticleId><ArticleId IdType="pubmed">15465786</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G., Meininger C.J., McNeal C.J., Bazer F.W., Rhoads J.M. Role of L-Arginine in nitric oxide synthesis and health in humans. Adv. Exp. Med. Biol. 2021;1332:167&#x2013;187. doi: 10.1007/978-3-030-74180-8_10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-74180-8_10</ArticleId><ArticleId IdType="pubmed">34251644</ArticleId></ArticleIdList></Reference><Reference><Citation>Rath M., Muller I., Kropf P., Closs E.I., Munder M. Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages. Front Immunol. 2014;5:532. doi: 10.3389/fimmu.2014.00532.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00532</ArticleId><ArticleId IdType="pmc">PMC4209874</ArticleId><ArticleId IdType="pubmed">25386178</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella J., et al. Arginine and endothelial function. Biomedicines. 2020;8:277. doi: 10.3390/biomedicines8080277.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8080277</ArticleId><ArticleId IdType="pmc">PMC7460461</ArticleId><ArticleId IdType="pubmed">32781796</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew P.J., Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res. 1999;43:521&#x2013;531. doi: 10.1016/s0008-6363(99)00115-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0008-6363(99)00115-7</ArticleId><ArticleId IdType="pubmed">10690324</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorens P.G., Vermeire P.A., Herman A.G. L-Arginine-dependent nitric oxide synthase: a new metabolic pathway in the lung and airways. Eur. Respir. J. 1993;6:258&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">7680323</ArticleId></ArticleIdList></Reference><Reference><Citation>Tousoulis D., Kampoli A.M., Tentolouris C., Papageorgiou N., Stefanadis C. The role of nitric oxide on endothelial function. Curr. Vasc. Pharm. 2012;10:4&#x2013;18. doi: 10.2174/157016112798829760.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157016112798829760</ArticleId><ArticleId IdType="pubmed">22112350</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormanns K., Brown R.G., David T. The role of nitric oxide in neurovascular coupling. J. Theor. Biol. 2016;394:1&#x2013;17. doi: 10.1016/j.jtbi.2016.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2016.01.009</ArticleId><ArticleId IdType="pubmed">26796228</ArticleId></ArticleIdList></Reference><Reference><Citation>Str&#xf6;hle A., von Bibra H., Hahn A. L-Arginine and vascular health. Med Mon. Pharm. 2016;39:515&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pubmed">29979511</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronte V., Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 2005;5:641&#x2013;654. doi: 10.1038/nri1668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1668</ArticleId><ArticleId IdType="pubmed">16056256</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijnands K.A., Castermans T.M., Hommen M.P., Meesters D.M., Poeze M. Arginine and citrulline and the immune response in sepsis. Nutrients. 2015;7:1426&#x2013;1463. doi: 10.3390/nu7031426.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu7031426</ArticleId><ArticleId IdType="pmc">PMC4377861</ArticleId><ArticleId IdType="pubmed">25699985</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli M.B., Gambardella J., Castellanos V., Trimarco V., Santulli G. Vitamin C and cardiovascular disease: an update. Antioxid. (Basel) 2020;9:1227. doi: 10.3390/antiox9121227.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9121227</ArticleId><ArticleId IdType="pmc">PMC7761826</ArticleId><ArticleId IdType="pubmed">33287462</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto M.E., Guarner-Lans V., Soria-Castro E., Manzano Pech L., Perez-Torres I. Is antioxidant therapy a useful complementary measure for Covid-19 Treatment? An algorithm for its application. Med. (Kaunas.) 2020;56 doi: 10.3390/medicina56080386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina56080386</ArticleId><ArticleId IdType="pmc">PMC7466376</ArticleId><ArticleId IdType="pubmed">32752010</ArticleId></ArticleIdList></Reference><Reference><Citation>Montel-Hagen A., et al. Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C. Cell. 2008;132:1039&#x2013;1048. doi: 10.1016/j.cell.2008.01.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.01.042</ArticleId><ArticleId IdType="pubmed">18358815</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., et al. Ascorbate recycling in human neutrophils: induction by bacteria. Proc. Natl. Acad. Sci. U. S. A. 1997;94:13816&#x2013;13819. doi: 10.1073/pnas.94.25.13816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.25.13816</ArticleId><ArticleId IdType="pmc">PMC28390</ArticleId><ArticleId IdType="pubmed">9391110</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer S.R., Kapoor A., Rath M., Thomas S.A. What is the role of supplementation with ascorbic acid, zinc, vitamin D, or N-acetylcysteine for prevention or treatment of COVID-19? Cleve Clin. J. Med. 2020 doi: 10.3949/ccjm.87a.ccc046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.87a.ccc046</ArticleId><ArticleId IdType="pubmed">32513807</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavarria A.P., et al. Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19. Comput. Struct. Biotechnol. J. 2021;19:1379&#x2013;1390. doi: 10.1016/j.csbj.2021.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2021.02.009</ArticleId><ArticleId IdType="pmc">PMC7910139</ArticleId><ArticleId IdType="pubmed">33680348</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr A.C., Rowe S. The emerging role of vitamin C in the prevention and treatment of COVID-19. Nutrients. 2020;12 doi: 10.3390/nu12113286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12113286</ArticleId><ArticleId IdType="pmc">PMC7693980</ArticleId><ArticleId IdType="pubmed">33121019</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J., Tie G., Messina L.M. Tetrahydrobiopterin, L-arginine and vitamin C act synergistically to decrease oxidative stress, increase nitricoxide and improve blood flow after induction of hindlimbischemia in the rat. Mol. Med. 2012;18:676&#x2013;684. doi: 10.2119/molmed.2011.00103.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2011.00103</ArticleId><ArticleId IdType="pmc">PMC3388126</ArticleId><ArticleId IdType="pubmed">22371305</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck J.L., et al. Ascorbic acid attenuates endothelial permeability triggered by cell-free hemoglobin. Biochem Biophys. Res. Commun. 2018;495:433&#x2013;437. doi: 10.1016/j.bbrc.2017.11.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.11.058</ArticleId><ArticleId IdType="pmc">PMC5736437</ArticleId><ArticleId IdType="pubmed">29129689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundblad C., Bentzer P. Effects of L-arginine on cerebral blood flow, microvascular permeability, number of perfused capillaries, and brain water content in the traumatized mouse brain. Micro Res. 2007;74:1&#x2013;8. doi: 10.1016/j.mvr.2007.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2007.03.001</ArticleId><ArticleId IdType="pubmed">17459424</ArticleId></ArticleIdList></Reference><Reference><Citation>May J.M., Qu Z.C. Nitric oxide mediates tightening of the endothelial barrier by ascorbic acid. Biochem Biophys. Res. Commun. 2011;404:701&#x2013;705. doi: 10.1016/j.bbrc.2010.12.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2010.12.046</ArticleId><ArticleId IdType="pmc">PMC3022079</ArticleId><ArticleId IdType="pubmed">21156160</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr A.C., Maggini S. Vitamin C and immune function. Nutrients. 2017;9 doi: 10.3390/nu9111211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9111211</ArticleId><ArticleId IdType="pmc">PMC5707683</ArticleId><ArticleId IdType="pubmed">29099763</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., et al. Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation. Front Cell Infect. Microbiol. 2022;12 doi: 10.3389/fcimb.2022.861703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Salazar B., et al. COVID-19 and the vasculature: current aspects and long-term consequences. Front Cell Dev. Biol. 2022;10 doi: 10.3389/fcell.2022.824851.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.824851</ArticleId><ArticleId IdType="pmc">PMC8887620</ArticleId><ArticleId IdType="pubmed">35242762</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Mone P., et al. L-Arginine enhances the effects of cardiac rehabilitation on physical performance: new insights for managing cardiovascular patients during the COVID-19 pandemic. J. Pharm. Exp. Ther. 2022;381:197&#x2013;203. doi: 10.1124/jpet.122.001149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.122.001149</ArticleId><ArticleId IdType="pmc">PMC9190231</ArticleId><ArticleId IdType="pubmed">35339987</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustin S.A., Nolan T. RT-qPCR testing of SARS-CoV-2: a primer. Int. J. Mol. Sci. 2020;21 doi: 10.3390/ijms21083004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21083004</ArticleId><ArticleId IdType="pmc">PMC7215906</ArticleId><ArticleId IdType="pubmed">32344568</ArticleId></ArticleIdList></Reference><Reference><Citation>Zha D., Fu M., Qian Y. Vascular endothelial glycocalyx damage and potentialtargeted therapy in COVID-19. Cells. 2022;11:1972. doi: 10.3390/cells11121972.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11121972</ArticleId><ArticleId IdType="pmc">PMC9221624</ArticleId><ArticleId IdType="pubmed">35741101</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella J., et al. Role of endothelial miR-24 in COVID-19 cerebrovascular events. Crit. Care. 2021;25:306. doi: 10.1186/s13054-021-03731-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03731-1</ArticleId><ArticleId IdType="pmc">PMC8385482</ArticleId><ArticleId IdType="pubmed">34433473</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P., et al. Endothelial dysfunction in COVID-19: a unifying mechanism and a potential therapeutic target. Biomedicines. 2022;10 doi: 10.3390/biomedicines10040812.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10040812</ArticleId><ArticleId IdType="pmc">PMC9029464</ArticleId><ArticleId IdType="pubmed">35453563</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella J., et al. Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19. J. Pharm. Exp. Ther. 2022 doi: 10.1124/jpet.122.001209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.122.001209</ArticleId><ArticleId IdType="pmc">PMC9827505</ArticleId><ArticleId IdType="pubmed">35772782</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz A., Ong P. Endothelial dysfunction in COVID-19: a potential predictor of long-COVID. Int. J. Cardiol. 2022;349:155&#x2013;156. doi: 10.1016/j.ijcard.2021.11.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2021.11.051</ArticleId><ArticleId IdType="pmc">PMC8610828</ArticleId><ArticleId IdType="pubmed">34838682</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou E., et al. Endothelial dysfunction in acute and long standing COVID-19: a prospective cohort study. Vasc. Pharm. 2022;144 doi: 10.1016/j.vph.2022.106975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2022.106975</ArticleId><ArticleId IdType="pmc">PMC8893931</ArticleId><ArticleId IdType="pubmed">35248780</ArticleId></ArticleIdList></Reference><Reference><Citation>Blann A.D., et al. Circulating endothelial cells. Biomark. Vasc. Dis. Thromb. Haemost. 2005;93:228&#x2013;235. doi: 10.1160/TH04-09-0578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH04-09-0578</ArticleId><ArticleId IdType="pubmed">15711737</ArticleId></ArticleIdList></Reference><Reference><Citation>Guervilly C., et al. Circulating endothelial cells as a marker of endothelial injury in severe COVID -19. J. Infect. Dis. 2020;222:1789&#x2013;1793. doi: 10.1093/infdis/jiaa528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa528</ArticleId><ArticleId IdType="pmc">PMC7454721</ArticleId><ArticleId IdType="pubmed">32812049</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh F.W., et al. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife. 2021;10 doi: 10.7554/eLife.64909.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64909</ArticleId><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollenberg R., et al. Indications of persistent glycocalyx damage in convalescent COVID-19 patients: a prospective multicenter study and hypothesis. Viruses. 2021;13 doi: 10.3390/v13112324.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112324</ArticleId><ArticleId IdType="pmc">PMC8619155</ArticleId><ArticleId IdType="pubmed">34835130</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J. Thromb. Haemost. 2021;19:2546&#x2013;2553. doi: 10.1111/jth.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S., et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front Cardiovasc. Med. 2021;8 doi: 10.3389/fcvm.2021.745758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S.D., Talwar A., Lee J.T. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324:2251&#x2013;2252. doi: 10.1001/jama.2020.22717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M., Caruezo V., Naveira A., Atanassoff P.G. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease. J. Clin. Anesth. 2020;66 doi: 10.1016/j.jclinane.2020.109926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2020.109926</ArticleId><ArticleId IdType="pmc">PMC7247969</ArticleId><ArticleId IdType="pubmed">32474331</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia L.F. Immune response, inflammation, and the clinical spectrum of COVID-19. Front Immunol. 2020;11:1441. doi: 10.3389/fimmu.2020.01441.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01441</ArticleId><ArticleId IdType="pmc">PMC7308593</ArticleId><ArticleId IdType="pubmed">32612615</ArticleId></ArticleIdList></Reference><Reference><Citation>Manson J.J., et al. COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study. Lancet Rheuma. 2020;2:e594&#x2013;e602. doi: 10.1016/S2665-9913(20)30275-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30275-7</ArticleId><ArticleId IdType="pmc">PMC7442426</ArticleId><ArticleId IdType="pubmed">32864628</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay M.Z., Poh C.M., Renia L., MacAry P.A., Ng L.F.P. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 2020;20:363&#x2013;374. doi: 10.1038/s41577-020-0311-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0311-8</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Budinger G.R.S., Misharin A.V., Ridge K.M., Singer B.D., Wunderink R.G. Distinctive features of severe SARS-CoV-2 pneumonia. J. Clin. Invest. 2021;131 doi: 10.1172/JCI149412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI149412</ArticleId><ArticleId IdType="pmc">PMC8279580</ArticleId><ArticleId IdType="pubmed">34263736</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavine J.S., Bjornstad O.N., Antia R. Immunological characteristics govern the transition of COVID-19 to endemicity. Science. 2021;371:741&#x2013;745. doi: 10.1126/science.abe6522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe6522</ArticleId><ArticleId IdType="pmc">PMC7932103</ArticleId><ArticleId IdType="pubmed">33436525</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas R., et al. Arginase 1: an unexpected mediator of pulmonary capillary barrier dysfunction in models of acute lung injury. Front Immunol. 2013;4:228. doi: 10.3389/fimmu.2013.00228.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00228</ArticleId><ArticleId IdType="pmc">PMC3736115</ArticleId><ArticleId IdType="pubmed">23966993</ArticleId></ArticleIdList></Reference><Reference><Citation>Reizine F., et al. SARS-CoV-2-induced ARDS associates with MDSC expansion, lymphocyte dysfunction, and arginine shortage. J. Clin. Immunol. 2021;41:515&#x2013;525. doi: 10.1007/s10875-020-00920-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-020-00920-5</ArticleId><ArticleId IdType="pmc">PMC7775842</ArticleId><ArticleId IdType="pubmed">33387156</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean M.J., et al. Transcriptome and functions of granulocytic myeloid-derived suppressor cells determine their association with disease severity of COVID-19. medRxiv. 2021 doi: 10.1101/2021.03.26.21254441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.26.21254441</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacchi A., et al. Expansion of myeloid derived suppressor cells contributes to platelet activation by L-Arginine deprivation during SARS-CoV-2 infection. Cells. 2021;10 doi: 10.3390/cells10082111.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10082111</ArticleId><ArticleId IdType="pmc">PMC8391818</ArticleId><ArticleId IdType="pubmed">34440879</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelzo M., et al. Inducible Nitric Oxide Synthase (iNOS): why a different production in COVID-19 patients of the two waves. Viruses. 2022;14 doi: 10.3390/v14030534.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030534</ArticleId><ArticleId IdType="pmc">PMC8948744</ArticleId><ArticleId IdType="pubmed">35336941</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinar R., Iyer M.R., Kunos G. Dual inhibition of CB1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID-19. Br. J. Pharm. 2022;179:2121&#x2013;2127. doi: 10.1111/bph.15461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15461</ArticleId><ArticleId IdType="pmc">PMC8251289</ArticleId><ArticleId IdType="pubmed">33769552</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Azizi S.A., Azizi S.A. Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/endothelial cells. J. Neurovirol. 2020;26:631&#x2013;641. doi: 10.1007/s13365-020-00903-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00903-7</ArticleId><ArticleId IdType="pmc">PMC7465881</ArticleId><ArticleId IdType="pubmed">32876900</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I., et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat. Commun. 2022;13:1745. doi: 10.1038/s41467-022-29440-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasannan N., et al. Impaired exercise capacity in post-COVID syndrome: the role of VWF-ADAMTS13 axis. Blood Adv. 2022 doi: 10.1182/bloodadvances.2021006944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021006944</ArticleId><ArticleId IdType="pmc">PMC9098525</ArticleId><ArticleId IdType="pubmed">35543533</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh S.Y., et al. Intravenous vitamin C administration reduces fatigue in office workers: a double-blind randomized controlled trial. Nutr. J. 2012;11:7. doi: 10.1186/1475-2891-11-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-2891-11-7</ArticleId><ArticleId IdType="pmc">PMC3273429</ArticleId><ArticleId IdType="pubmed">22264303</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson C.M., Levin R.D., Spector T., Lis C.G. Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother. Pharm. 2013;72:139&#x2013;146. doi: 10.1007/s00280-013-2179-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00280-013-2179-9</ArticleId><ArticleId IdType="pmc">PMC3691494</ArticleId><ArticleId IdType="pubmed">23670640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceriello A., et al. Vitamin C further improves the protective effect of glucagon-like peptide-1 on acute hypoglycemia-induced oxidative stress, inflammation, and endothelial dysfunction in type 1 diabetes. Diabetes Care. 2013;36:4104&#x2013;4108. doi: 10.2337/dc13-0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc13-0750</ArticleId><ArticleId IdType="pmc">PMC3836129</ArticleId><ArticleId IdType="pubmed">24130351</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillani S.W., Sulaiman S.A.S., Abdul M.I.M., Baig M.R. Combined effect of metformin with ascorbic acid versus acetyl salicylic acid on diabetes-related cardiovascular complication; a 12-month single blind multicenter randomized control trial. Cardiovasc. Diabetol. 2017;16:103. doi: 10.1186/s12933-017-0584-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-017-0584-9</ArticleId><ArticleId IdType="pmc">PMC5556597</ArticleId><ArticleId IdType="pubmed">28807030</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>